MANNKIND CORP·4

Jun 25, 9:00 PM ET

Marasco Dominic 4

4 · MANNKIND CORP · Filed Jun 25, 2025

Insider Transaction Report

Form 4
Period: 2025-06-23
Marasco Dominic
Pres, Endocrine Business Unit
Transactions
  • Award

    Performance Restricted Stock Unit

    2025-06-23+1,000,0001,000,000 total
    Common Stock, $0.01 Par Value (1,000,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
  • [F2]The performance-based restricted stock unit will vest on March 15, 2028. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, will be determined by the achievement of a specified net sales target, with the potential payout ranging from 0% to 200%.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4